Asia Pacific & Australia
Australia: Montu Tells Patients They Have Discontinued Cannatrek’s T25 Topaz Flower because of “poor reliability and quality”
Ouch !
Cannabiz Australia report
Read more https://www.cannabiz.com.au/showdown-looms-between-montu-and-cannatrek-over-product-claims/
We found this interesting snippet in a recent issue of Pharmacy Daily
Dated 17 March 2023
We are seeing retailers selling approximately an ounce of the product at $A280 online
Let’s say for argument that retailers are doubling wholesale prices.
Our guesstimate (if Huppert is telling the truth) is that Canntrek have turned over $A70 million on this one product alone!
Are they really making this sort of money?
It would be interesting to know especially if the product is as Montu say of poor reliability and quality
All we will say is that somebody is obviously making a tidy profit off less than perfect product and we can extrapolate that further by saying that these products are being defined as pharmaceutical, not food or general agricultural so what are the TGA doing, if anything, about these allegations by Montu.